MedPath

Role of herbal medicine in Gout disease

Phase 2
Conditions
Health Condition 1: M109- Gout, unspecified
Registration Number
CTRI/2024/07/071522
Lead Sponsor
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients of classical sign and symptoms of Vatarakta (Gout)with serum uric acid level greater than 7mg/dl in males and 6mg/dl in females.

2. Age 16 to 70 years, of either sex.

3. Patients willing to undergo trial.

Exclusion Criteria

1. Not willing to undergo trial.

2. Patients having other associated arthropathies.

3. Patients taking modern medicines like uricosuric or xanthine oxidase inhibitors.

4. Contraindication of Siravedh.

5. Patients suffering from any bleeding disorders, pregnancy, anemia, uncontrolled diabetes mellitus will be excluded from the study.

6. Existing or less than 2 weeks ago oral treatment with corticosteroids or colchicine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
relief in sign and symptoms of Vatarakta (Gout), decrease level of Uric acid in BloodTimepoint: 2 months
Secondary Outcome Measures
NameTimeMethod
relief in sign and symptoms of Vatarakta (Gout), decrease level of Uric acid in BloodTimepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath